What dose of Mounjaro works best — and how does anyone know?

Why does everyone start at 2.5 mg if higher doses work better?

The first pen's job is adjustment, not weight reduction. Mounjaro activates two gut-hormone receptors, GIP and GLP-1, simultaneously, and that dual action is more potent than a single-pathway medicine. Starting at the lowest strength means the GI effects (nausea, loose stools, fullness arriving fast) tend to be mild and brief rather than stopping people in their tracks. Most people find these settle within one to two weeks at each level.

From 2.5 mg, doses move up in four-week steps: 2.5 mg, then 5 mg, which is the second rung of the titration ladder, then 7.5 mg, and so on toward the 15 mg maximum. Titration is not automatic. Your prescriber reviews how you are tolerating each strength before a dose increase goes ahead. If side effects are still significant at week four, staying at the current dose for longer is a legitimate clinical decision. Rushing the ladder rarely helps and often sets people back.

The NHS patient information for tirzepatide explains this schedule clearly; the NHS medicines page for tirzepatide is worth reading before you start.

Does a higher dose always mean better results?

In the trials, broadly yes, but with an important caveat. SURMOUNT-1, which involved 2,539 adults with obesity, found that 15 mg produced around 20–21% average weight loss over 72 weeks, compared with roughly 15% at 5 mg and around 19% at 10 mg. The gap between 10 mg and 15 mg is real but narrower than the gap between 5 mg and 10 mg. The maximum 15 mg dose is the ceiling for a reason, not a starting aspiration.

What the averages mask is individual variation. Some people reach a dose that suits them and stay there comfortably for months, losing steadily without needing the next step. Others tolerate the full 15 mg well from an early stage and find the higher dose necessary to shift a plateau. There is no universal answer, which is exactly why the prescriber relationship matters throughout treatment, not just at the start.

For those thinking about the broader evidence on tirzepatide versus semaglutide, a comparison of tirzepatide dosing and results sets the SURMOUNT data alongside the STEP trials.

What happens if a dose stops working or side effects don't settle?

Weight loss with Mounjaro is rarely linear. A plateau at a lower dose is not a sign the medicine has failed; it can mean the dose needs to move up, or that lifestyle factors around eating and activity are worth revisiting with your prescriber. NICE's appraisal of tirzepatide, TA1026, sets a clear checkpoint: if you have not lost at least 5% of body weight after six months on the highest dose you can tolerate, continuing treatment should be reviewed.

Side effects that do not settle after a few weeks at a given dose are a different kind of signal. Persistent nausea, vomiting or diarrhoea severe enough to affect daily life generally means staying at the current dose for longer, or discussing a temporary step down with your prescriber. Dose changes in either direction are clinical decisions made with real information, not something to navigate alone. If you miss a dose while working this out, the guidance on missed doses is straightforward and worth knowing.

On the question of cost as doses rise, a clear overview of treatment options and pricing context helps set expectations before a consultation.

How does nume settle on a dose at each review?

At nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before it is dispensed. That is not a formality. Prescribers look at your weight, your side-effect history and how long you have been on your current strength before confirming or adjusting the next supply, and if you are weighing up what the best dose of Mounjaro for weight loss actually looks like, that review conversation is a good place to explore it. Transfer patients coming from another provider bring their current dose history, and we check that evidence before moving anything. The clinical team follows the same stepped-titration logic that the SmPC and NICE guidance describe.

When an approved prescription goes out, the pen ships the same day if ordered before 12pm on a working day, arriving the next working day via DPD in plain, unbranded packaging, the tracking notification tends to arrive before most people have had lunch. The pen itself, a Mounjaro KwikPen, goes straight into the fridge on arrival; 2–8°C is the storage range confirmed in the SmPC. If you are ready to find out which dose of Mounjaro is best for your weight loss goals, start your free consultation and a prescriber will review your answers the same day.